Collaborative analysis of disease and death drivers in Gaza conflict

The analysis was conducted to help better address the humanitarian crisis in Gaza both during and after the war.

Allakos halves workforce, drops lead inflammatory program

California biotech Allakos said it would end development of its lead inflammatory disease program and lay off half of its workforce to save costs. The

January 17, 2024

Almirall sees highest filings and grants during August in Q3 2023

Share this article Almirall has been focused on protecting inventions in European Patent Office(EPO) with 4 publications in Q3 2023 The European Patent Office(EPO) Patent

December 11, 2023

Tune Therapeutics unveils potentially curative approach to treating chronic HBV infection

Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection.

November 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.